Medifast, Inc. (MED) Misses Q4 EPS by 13c; Issues Mixed Guidance
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.17 +2.10%
EPS Growth %: -195.2%
Financial Fact:
Interest income/ (expense), net: 60K
Today's EPS Names:
OCCI, IPX, ALZN, More
EPS Growth %: -195.2%
Financial Fact:
Interest income/ (expense), net: 60K
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q4 EPS of $0.08, $0.13 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $69 million versus the consensus estimate of $70.97 million.
Medifast, Inc. sees Q1 2012 EPS of $0.36-$0.38, versus the consensus of $0.45. Medifast, Inc. sees Q1 2012 revenue of $86.5-$88.5 million, versus the consensus of $83.4 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Medifast, Inc. sees Q1 2012 EPS of $0.36-$0.38, versus the consensus of $0.45. Medifast, Inc. sees Q1 2012 revenue of $86.5-$88.5 million, versus the consensus of $83.4 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- S&P downgrades Cable One to ’B+’ on weakening broadband outlook
- MVB Bank partners with DingoBlu on mobile banking platform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
